Anti-DB125/ DEFB125/ DEFB-25 functional antibody

Anti-DB125/ DEFB125/ DEFB-25 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to DEFB125/DEFB125 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0870-Ab-1/ GM-Tg-hg-SE0870-Ab-2Anti-Human DEFB125 monoclonal antibodyHuman
GM-Tg-rg-SE0870-Ab-1/ GM-Tg-rg-SE0870-Ab-2Anti-Rat DEFB125 monoclonal antibodyRat
GM-Tg-mg-SE0870-Ab-1/ GM-Tg-mg-SE0870-Ab-2Anti-Mouse DEFB125 monoclonal antibodyMouse
GM-Tg-cynog-SE0870-Ab-1/ GM-Tg-cynog-SE0870-Ab-2Anti-Cynomolgus/ Rhesus macaque DEFB125 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0870-Ab-1/ GM-Tg-felg-SE0870-Ab-2Anti-Feline DEFB125 monoclonal antibodyFeline
GM-Tg-cang-SE0870-Ab-1/ GM-Tg-cang-SE0870-Ab-2Anti-Canine DEFB125 monoclonal antibodyCanine
GM-Tg-bovg-SE0870-Ab-1/ GM-Tg-bovg-SE0870-Ab-2Anti-Bovine DEFB125 monoclonal antibodyBovine
GM-Tg-equg-SE0870-Ab-1/ GM-Tg-equg-SE0870-Ab-2Anti-Equine DEFB125 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0870-Ab-1/ GM-Tg-hg-SE0870-Ab-2; GM-Tg-rg-SE0870-Ab-1/ GM-Tg-rg-SE0870-Ab-2;
GM-Tg-mg-SE0870-Ab-1/ GM-Tg-mg-SE0870-Ab-2; GM-Tg-cynog-SE0870-Ab-1/ GM-Tg-cynog-SE0870-Ab-2;
GM-Tg-felg-SE0870-Ab-1/ GM-Tg-felg-SE0870-Ab-2; GM-Tg-cang-SE0870-Ab-1/ GM-Tg-cang-SE0870-Ab-2;
GM-Tg-bovg-SE0870-Ab-1/ GM-Tg-bovg-SE0870-Ab-2; GM-Tg-equg-SE0870-Ab-1/ GM-Tg-equg-SE0870-Ab-2
Products NameAnti-DEFB125 monoclonal antibody
Formatmab
Target NameDEFB125
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DEFB125 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0870-Ag-1Recombinant multi-species DB125/ DEFB125/ DEFB-25 protein


    Target information

    Target IDGM-SE0870
    Target NameDEFB125
    Gene ID245938,654457,641629,714029,100683603,101088480,112449322
    Gene Symbol and SynonymsCBD125,DEFB-25,DEFB125,Defb26,EG654457
    Uniprot AccessionQ8N687
    Uniprot Entry NameDB125_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000178591
    Target ClassificationN/A

    The target: DEFB125, gene name: DEFB125, also named as DEFB-25. Defensins are cysteine-rich cationic polypeptides that are important in the host immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13. [provided by RefSeq, Nov 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.